From Financialisation to Innovation in UK Big Pharma
- 116 páginas
- 5 horas de lectura
This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.